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Immunity to the intestinal parasite Heligomoso-
moides polygyrus is dependent on the successful
generation of T helper 2 (Th2) memory cells. We
showed that B cells contribute to immunity against
H. polygyrus by producing antibody (Ab) and by
promoting expansion and differentiation of primary
and memory Th2 cells. We also demonstrated that
cytokine-producing effector B cells were essential
for effective immunity to H. polygyrus. Tumor
necrosis factor alpha production by B cells was
necessary for sustained Ab production, whereas
interleukin 2 production by B cells was necessary
for Th2 cell expansion and differentiation. These
results show that B cells mediate protection from
pathogens not only by presenting antigen and
secreting antibody but also by producing cytokines
that regulate the quality and magnitude of humoral
and cellular immune responses.
INTRODUCTION
B lymphocytes produce antibodies (Abs) that facilitate clear-
ance of pathogens and other antigens. However, emerging
data regarding mice and patients treated with a B cell-depleting
Ab (Rituxan [Rituximab], also known as MabThera) suggest that
B cells may regulate immune responses by additional, Ab-inde-
pendent mechanisms. For example, auto-Ab titers do not drop
substantially in B cell-depleted patients with systemic lupus
erythematosus (SLE) (Cambridge, 2004; Looney et al., 2004),
yet these patients often experience complete clinical remission
for many months or years. Likewise, autoimmune-prone mice
that are B cell sufficient but unable to produce auto-Abs still
exhibit symptoms of autoimmune pathology (Chan et al.,
1999). Thus, B cells can be both protective and pathologic
and appear to regulate immune responses by multiple mecha-
nisms.There are many ways, both Ab dependent and Ab indepen-
dent, by which B cells regulate immune responses to pathogens
(Baumgarth et al., 2008; Dorner and Radbruch, 2007; Gray et al.,
2007; Stephens and Langhorne, 2006). B cells express toll-like
receptors (Gray et al., 2007) and when activated also express
costimulatory molecules (Linton et al., 2000; Linton et al.,
2003). Activated B cells are also excellent antigen-presenting
cells (APCs) that can selectively internalize specific antigen
through the B cell receptor (BCR), facilitating antigen processing
and presentation to CD4+ T cells (Chen and Jensen, 2008; Lund
et al., 2005). In fact, there is growing evidence to suggest that
antigen-presenting B cells shape the magnitude and quality of
the primary and memory CD4+ T cell response, particularly
when antigen is limiting (Cardillo et al., 2007; Crawford et al.,
2006; Gillan et al., 2005; Iijima et al., 2008; Linton et al., 2000;
Liu et al., 2007; Lund et al., 2006; McClellan et al., 2006; Ronet
et al., 2008; Stephens and Langhorne, 2006). B cells also influ-
ence immune responses by producing cytokines (reviewed in
Lund, 2008; Lund et al., 2005). For example, production of lym-
photoxin (LTa) by B cells is necessary for the differentiation of
follicular dendritic cells (DCs) (Endres et al., 1999; Fu et al.,
1998), the formation of B cell follicles (Gonzalez et al., 1998),
and the development of specialized stromal cells in the spleen
(Ngo et al., 2001). Tumor necrosis factor alpha (TNFa) production
by B cells can influence the generation of interferon gamma
(IFNg)-producing effector T cells (Menard et al., 2007), whereas
interleukin 10 (IL-10) production by B cells alters DC function
and modulates T cell priming and effector T cell development
(Moulin et al., 2000; Sun et al., 2005). In addition, IL-10-
producing B cells (also known as Bregs) can act directly on
effector T cells and repress T cell cytokine production, thereby
suppressing a number of T cell-mediated inflammatory
diseases, including SLE, experimental autoimmune encephalo-
myelitis, and collagen-induced arthritis (reviewed in Fillatreau
et al., 2008; Mizoguchi and Bhan, 2006).
B cells also secrete other cytokines, including IL-2, IL-4, IL-13,
IFNg, and IL-12 (reviewed in (Lund et al., 2005; Pistoia, 1997);
however, the functional role of these B cell-derived cytokines
is largely unknown. We previously demonstrated that B cells
can be subdivided into at least two different effector B cellImmunity 30, 421–433, March 20, 2009 ª2009 Elsevier Inc. 421
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2000). B cells primed by cognate interactions with Th1 cells
(Be-1 cells) produce IFNg, IL-12p40, TNFa, and IL-10, whereas
B cells primed by cognate interactions with Th2 cells (Be-2 cells)
produce IL-4, IL-2, IL-13, IL-6, IL-10, and TNFa. The signals that
regulate the differentiation of these two subsets are distinct, with
Be-1 cells developing in response to IFNg and IL-12 (Harris et al.,
2005a) and Be-2 cells developing in response to IL-4 (Harris
et al., 2005b). Interestingly, Be-1 and Be-2 cells can prime naive
CD4+ T cells to differentiate into Th1 cell- and Th2 cell-like effec-
tors in vitro (Harris et al., 2000), suggesting that these cytokine-
producing effector B cells may function to amplify T cell-depen-
dent immune responses in vivo.
In this manuscript, we directly evaluated whether cytokine-
producing effector B cells are required for protection from the
intestinal nematode, Heligmosomoides polygyrus (Hp). We
show that B cells were required for protection from Hp and
that B cells mediated protection by producing Ab and by sup-
porting the expansion and differentiation of primary and memory
Th2 cells. We further demonstrate that cognate interactions
between B and T cells are required for robust Th2 cell responses
and that B cells regulate Th2 cell responses independently of Ab
production. Importantly, we show that IL-4Ra expression by
B cells is required for protection, suggesting that IL-4 primed
Be-2 cells regulate immunity to H. polygyrus. In agreement
with this finding, we demonstrate that B cell-derived IL-2 and
TNFa regulates Ab and T cell responses to Hp and that the
production of these cytokines by B cells was needed for protec-
tion. Thus, these data show that cytokine-producing effector
B cells play important roles in the establishment and mainte-
nance of humoral and cellular immune responses and are criti-
cally important for protection against some pathogens.
RESULTS
Protective Immunity to Hp Is Dependent on B Cells
Oral inoculation of mice with Hp stage 3 larvae (L3 Hp) results in
the establishment of a chronic infection (Finkelman et al., 1997;
Gause et al., 2003). The L3 Hp enter the submucosa of the small
intestine, mature, and emerge into the lumen as adult parasites
after one week. Immunocompetent mice mount a robust primary
Th2 cell response to the infection. However, this immune
response is unable to prevent the establishment of a chronic
infection with the adult parasites. Parasitized animals can be
cured of the chronic infection by treatment with pyrantel
pamoate. Drug-cured mice respond rapidly to challenge infec-
tions with L3 Hp and are able to prevent the emergence of adult
parasites. The protective recall response is dependent on IL-4-
producing Th2 cells (Liu et al., 2004; Urban et al., 1991), as
well as alternatively activated macrophages (Anthony et al.,
2006). However, the role of B cells in this response is unknown.
To determine whether B cells are required for the generation of
a protectivememory response toHp, we orally infected C57BL/6
and BALB/c mice, as well as B cell-deficient mMT and JHDmice,
with L3Hp. The infectedmicewere treated threeweeks later with
pyrantel pamoate for elimination of the adult parasites from the
intestine. We repeated this infection and drug-treatment cycle
a second time to ensure the development of a robust memory
immune response. Immune mice, as well as naive controls,422 Immunity 30, 421–433, March 20, 2009 ª2009 Elsevier Inc.were then challenged with L3 Hp, and parasites in the small
intestine were enumerated 20 days later. As expected, C57BL/6
(Figure 1A) or BALB/c (Figure 1B) mice given a primary infection
harbored substantial numbers of adult Hp parasites in the small
intestine, whereas the previously infected C57BL/6 (Figure 1A)
and BALB/c (Figure 1B) mice (memory C57BL/6 mice and
memory BALB/c mice) effectively prevented the emergence of
adult parasites. In contrast, memory mMT (Figure 1A) and
memory JHD (Figure 1B) mice harbored large numbers of adult
parasites—equivalent to that seen in mice given a primary infec-
tion. Thus, B cells are required for the generation of a protective
memory immune response to Hp.
To determine whether the failure of B cell-deficient mice to
mount a protective memory immune response to Hp was due
to alterations in the establishment of the initial infection, we
infected naive C57BL/6 and mMTmice with L3Hp andmeasured
the emergence of adult parasites into the intestinal lumen over
the next three weeks. As shown in Figure 1C, the emergence
of adult parasites into the lumen was identical in C57BL/6 and
mMT mice in terms of both magnitude and kinetics. Next, to
test whether a memory immune response to Hp was initiated
in the absence of B cells, we infected naive C57BL/6 and mMT
mice with L3 Hp, waited 21 days for the establishment of
a chronic infection, then treated the infected mice and a cohort
of naive mice with pyrantal pamoate to eliminate the adult para-
sites in the infected mice. Two weeks later, we infected the naive
mice and the previously infected mice with L3 Hp and measured
the emergence of adult parasites into the lumen of the intestine.
In the C57BL/6 and mMT animals receiving a primary infection,
adult parasites began emerging on day 7, reaching maximal
levels between days 8 and 9 (Figure 1D), whereas adult parasites
began emerging from memory C57BL/6 and mMT mice on day 8
(Figure 1D). Only a small number of adult parasites were found in
the memory B6 mice (Figure 1D). In contrast, the memory mMT
mice had significantly greater numbers (p < 0.003) of healthy
adult parasites present in the lumen on day 8, and by postchal-
lenge days 10–12, the number of adult parasites present in the
intestine was equivalent to that seen in primary-infection mice
(Figure 1D). Thus, although an immune response to Hp was initi-
ated in B cell-deficient mice, it was neither sustained nor protec-
tive and only modestly delayed the entry of adult worms into the
intestinal lumen.
Protective Immunity to Hp Is Not Regulated
by B Cell-Dependent Lymphoid-Tissue Organogenesis
The prior experiments were performedwith B cell-deficient mice.
It is known that B cells organize the cellular composition and
architecture of the spleen (Ngo et al., 2001) and are necessary
for the organogenesis of Peyer’s patches (PP) (Golovkina et al.,
1999). It is reported that bone marrow (BM) reconstitution does
not rescue the lymphoid-tissue developmental defects in mMT
mice (Golovkina et al., 1999; Ngo et al., 2001), indicating that
B cells must be present during fetal ontogeny to promote proper
development of the PP and spleen. These B cell-dependent
defects in lymphoid-tissue organogenesis are known to alter
the development of some DC and T cell subsets (Ngo et al.,
2001), and this alteration has the potential to affect immune
responses. Thus, it was possible that the inability of B cell-defi-
cient mice to clear Hp could simply be due to a requirement for
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(A and B) C57BL/6 and mMT mice (A) or BALB/c and JHD mice (B) were exposed to two rounds of L3 Hp infection and drug treatment with pyrantel pamoate.
The memory mice (secondary) and a group of naive mice (primary) were then challenged with L3 Hp, and parasite burdens were determined on day 20.
(C) C57BL/6 and mMTmice were infected with L3 Hp, and the number of adult parasites in the intestine was determined on days 6, 7, 8, 9, 10, and 21 after infec-
tion. The data are shown as mean ± SD (n = 3–4 mice per group per time point).
(D) C57BL/6 and mMTmicewere infectedwith L3Hp or were sham infected. Threeweeks later, all micewere treatedwith pyrantel pamoate. Ten days after the last
drug treatment, all mice were infected with L3 Hp. The number of adult parasites present in the intestinal lumen of the previously infected mice (secondary) and
previously naive mice (primary) was determined at the times indicated. The data are shown as mean ± SD (n = 3–4 mice per group per time point).
The results shown are representative of two or more independent experiments.B cells during fetal lymphoid-tissue development. To determine
whether the loss of B cells during organogenesis was respon-
sible for the increased susceptibility of these mice to Hp, we
transferred BM fromC57BL/6 or mMTmice into lethally irradiated
mMT hosts to generate animals that lacked B cells during embry-
onic development but were either B cell sufficient or B cell defi-
cient at the time of infection (Figure S1A, available online). After
exposing the BM chimeric mice to two rounds of L3 Hp infection
and pyrantal pamoate treatment, we challenged the mice with
larvae and determined the number of adult parasites on day 15.
As expected, mMT mice reconstituted with mMT BM lacked B
cells (Figure S1B) andwere unable tomount a protective immune
response to Hp (Figure S1C). However, mMT mice reconstituted
with C57BL/6 BM were able to express B cells (Figure S1B) and
were fully protected from reinfection (Figure S1C) despite having
a disorganized spleen and lacking PPs. Together, these data
demonstrate that immunity to Hp is not dependent on the pres-
ence of B cells during fetal development. Instead, the data
suggest that B cells mediate their protective effect during the
course of the immune response to Hp.
Hp-Specific Ab Is Necessary for Protection
Althoughwe showed a role for B cells during the establishment of
a protective immune response to Hp, it was unclear how B cells
might mediate protection. The role for Ab in immunity to mostnematodes is controversial, the majority of groups reporting
minimal impact of Ab on pathogen clearance (Anthony et al.,
2007). IgE is the only Ab isotype previously tested for efficacy
in immunity to Hp, and, despite the robust IgE response that is
generated after Hp infection, IgE is dispensable for protection
from Hp (Anthony et al., 2007; Finkelman et al., 1997). To deter-
mine whether other isotypes of Ab were necessary for protec-
tion, we performed a Hp challenge infection in B cell-sufficient
(C57BL/6), B cell-deficient (mMT), and secretory IgM-deficient
(ms) mice (Boes et al., 1998) and compared protection in these
mice to mice that are deficient in both secretory IgM and activa-
tion-induced deaminase (AID, gene name Aicda) (ms–Aicda/
mice). These doubly deficient (ms–Aicda/) mice are unable to
undergo affinity maturation or secrete Ab of any isotype (Kuma-
zaki et al., 2007). Mice were exposed to two rounds of infection
and drug treatment prior to the final challenge infection. We
enumerated B cells, Ab titers, and parasite burdens on day 13
after the final challenge infection. Activated B cells with
a germinal-center phenotype (CD19+PNAhiFAS+) were detected
in the mesenteric lymph nodes (mLNs) of infected C57BL/6, ms,
and ms–Aicda/ mice but were not found in any tissues of mMT
mice (Figure 2A). Similar to a previous report (Hase et al., 2008),
larger numbers of germinal center B cells were present in mice
lacking AID. As expected, no Ab of any isotype was detected
in the infected mMTmice (Figures 2B and 2C), and these animalsImmunity 30, 421–433, March 20, 2009 ª2009 Elsevier Inc. 423
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was not detected in serum from the Hp-infected ms mice
(Figure 2B), but these mice were able to secrete Hp-specific
class-switched IgG1 (Figure 2C) and IgE (data not shown). In
contrast, the ms–Aicda/ mice could not secrete any Ab,
regardless of isotype (Figures 2B and 2C). Interestingly, the ms
mice efficiently cleared the challenge Hp infection, in spite of
lacking Hp-specific IgM (Figure 2D). However, the ms–Aicda/
mice were not protected from reinfection (Figure 2D). Together,
the data suggest that a class-switched (non-IgE) affinity-
matured Ab response is needed for protection from Hp.
Next, to address whether Ab production was the only effector
function of B cells required for immunity to Hp, we performed
serum-transfer experiments. We exposed C57BL/6 and mMT
mice to two rounds of Hp infection and pyrantal pamoate treat-
ment.We then injected themMTmemorymicewith normalmouse
serum or serum from Hp-immune C57BL/6 mice three times—
two days before a final challenge with Hp larvae, the day of chal-
lenge, and two days after the challenge infection. We measured
parasite burden in the intestine 19 days after the final challenge.
Despite detection of the transferred Hp-specific IgG1 in mMT
recipients for at least two weeks after transfer (data not shown),
Figure 2. Isotype-Switched Ab Is Neces-
sary But Not Sufficient for Protection from
Hp Challenge
C57BL/6, mMT, ms, or ms–Aicda/ mice were
exposed to two rounds of infection with L3 Hp
and drug treatment with pyrantel pamoate.
(A–C) Mice were challenged with L3 Hp and the
(A) number of CD19+PNAhiFAS+ germinal center
B cells in the mLNs was determined 13 days later
by flow cytometry. Titers of (B) Hp-specific IgM
and (C) Hp-specific IgG1 were determined by
ELISA.
(D) The number of adult parasites present in the
intestinal lumen was determined.
(E) C57BL/6 and mMT mice were exposed to two
rounds of Hp infection and drug treatment.
200 ml of Hp immune serum (IS) or normal mouse
serum (NMS) was injected (i.p.) into the memory
mMT and B6 recipients two days before, the day
of, and two days after a challenge infection with
Hp. Parasite burdens were determined 19 days
later. Data are represented as the mean ± SD
(n = 10 mice per group).
Data are representative of two individual experi-
ments.
no protection was observed in the
memory mMT mice that received immune
serum (Figure 2E). Taken together, these
data suggest that although Hp-specific
Ab is necessary for protection, it may not
be sufficient to mediate protection in
mMT mice.
B Cells Are Required for the
Development of Hp-Specific
Primary Effector Th2 Cells
Collectively, our data suggested that B
cells might play both an Ab-dependent
and an Ab-independent role in protection from Hp. Given the
critical role of Th2 cells in protection from Hp (Liu et al., 2004),
we next asked whether B cells are necessary for the initial
priming or expansion of effector Th2 cells. To test this hypoth-
esis, we intercrossed 4get IL-4 reporter mice (EGFP expression
reports IL-4 transcription [Mohrs et al., 2001]) with mMT mice to
generate B cell-deficient IL-4 reporter mice (4getmMT). To elim-
inate the confounding variable of B cell deficiency during
lymphoid-tissue development and its potential impact on T cell
responses (Ngo et al., 2001), we again made BM chimeras by
using lethally irradiated mMT hosts reconstituted with either
4getmMT BM for generating the B cell-deficient 4getmMT
chimeras or with 4get BM for generating the B cell-sufficient
4get chimeras (see Figure S2A). We infected both groups of
chimeric mice with Hp larvae and then used FACS analysis to
determine the percentage and number of IL-4 transcript
(EGFP+)-expressing CD4+ T cells present in the mLNs of the in-
fected 4get and 4getmMT mice (Figure S2B). As shown in
Figure 3A, the numbers of EGFP+CD62LloCD4+ T cells began
to increase in the mLNs between days 5 and 8 after infection.
At this time, the number of EGFP+CD62LloCD4+ T cells was
significantly (p % 0.02) higher in the 4get chimeras than in the424 Immunity 30, 421–433, March 20, 2009 ª2009 Elsevier Inc.
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Cell Commitment, Expansion, and Differen-
tiation
B cell-deficient mMT mice were lethally irradiated
and reconstituted with 4get BM (4get chimeras)
or with B cell-deficient 4get BM (4getmMT
chimeras).
(A) The chimeric mice were infected with Hp, and
the number of EGFP+CD62LloCD4+ T cells in the
mLNs was determined by flow cytometry at
various times.
(B) Cells from the mLNs were stimulated with
plate-bound anti-CD3 for 4 hr in the presence of
Brefeldin A, and the numbers of IL-4+EGFP+
CD4+ T cells were determinedwith flow cytometry.
Data are shown as the mean ± SD of 4–5 mice per
group per time point.
‘‘*’’: Statistically significant differences (p % 0.02)
between the 4get and 4getmMT groups were
found at each of the indicated time points. ‘‘#’’:
Statistically significant differences (p % 0.05)
between day 0 4getmMT mice and day 8 4getmMT
mice are indicated.
(C) C57BL/6 and mMTmice were infected with L3 Hp, and CD4+ cells were purified from pooled mLNs 21 days later. Purified CD4+ T cells were restimulated with
Hp antigen-pulsed APCs, and cytokine levels in the supernatants were determined by cytometric bead array.
The results shown are representative of three independent experiments.B cell-deficient 4getmMT chimeras—a trend that continued
through day 18 (Figure 3A).
Next, to assess the functionality of the few IL-4 transcript-
expressingCD4+Tcells present in the4getmMTmLNs,we isolated
cells from the infectedmice at various times after infection, stimu-
lated the cells with plate-bound anti-CD3, then assessed IL-4
protein production by the EGFP+CD4+ T cells (Figure S2C). Inter-
estingly, although a large proportion of the EGFP+CD4+ T cells
from the 4get chimeras produced IL-4 upon anti-CD3
restimulation, almost no IL-4-producing T cells were identified in
4getmMT chimeras at any time point examined (Figure 3B). To
confirm that thesedata from the reportermiceaccurately reflected
functional differences in Hp-specific Th2 cells, we purified CD4+
T cells from the mLNs of day 21 Hp-infected C57BL/6 and mMT
mice, restimulated them with Hp antigen-pulsed APCs, and
measured cytokine production in the supernatant. As shown in
Figure 3C, CD4+ T cells from C57BL/6 mice produced IL-4, IL-5,
IL-10, and IL-13 upon restimulation with Hp antigen, whereas
T cells from mMTmice produced low to undetectable amounts of
these cytokines (Figure 3C). These data demonstrate that B cells,
althoughnotnecessarilyobligate forTcellpriming,areessential for
the optimal expansion and differentiation of functional antigen-
specific effector Th2 cells during the primary response to Hp.
Th2 Memory Cell Responses to Hp Are Dependent
on the Presence of B Cells
Given the importance of B cells during the initial expansion of
Hp-specific effector Th2 cells, we then addressed whether B cells
were needed for generation of an optimal memory Th2 cell
response. We again reconstituted irradiated mMT hosts with
4getmMT or 4get BM to generate the same two groups of chimeric
miceused in thepreviousexperiment (seeFigureS2A).We infected
both groups of chimeric mice with L3 Hp, cured them of infection
with pyrantal pamoate on day 21, and rested the mice until day
60. Using FACS analysis, we found that the frequency of CD4+T cells that were EGFP+CD62Llo was reduced by half in the mLNs
of the memory B cell-deficient 4getmMT BM chimeras (Figure 4A).
To address whether thesememory cells were able to expand after
a challenge infection, we inoculated a cohort of the day 60memory
mice with L3 Hp and compared the percentage and number of
EGFP+CD4+ T cells in the mLNs of the mice at various time points
after challenge. As shown in Figure 4B, the frequency of
EGFP+CD62LloCD4+ T cells was greatly reduced in the day 5 post-
challenge 4getmMT chimeras. Furthermore, the number of
EGFP+CD62Llo T cells in the mLNs of 4getmMT mice was signifi-
cantly (p% 0.002) and dramatically decreased relative to those in
the 4get chimeras at all time points after challenge (Figure 4C).
To assess the functionality of the memory CD4+ T cells in the
4getmMT mice, we isolated mLN cells from the memory and
rechallenged mice, stimulated them with plate-bound anti-
CD3, and assessed IL-4 production by the EGFP+CD4+ T cells.
The frequency of IL-4-expressing EGFP+CD4+ T cells was
essentially identical between the 4get and 4getmMT chimeras
regardless of whether the T cells were resting memory cells
(Figure 4D) or reactivated memory cells (Figure 4E). However,
when we calculated the number of IL-4-producing EGFP+CD4+
T cells present in the mLNs of 4get and 4getmMT chimeras, we
observed a dramatic reduction in the number of cytokine-
producing effector memory T cells in the B cell-deficient animals
(Figure 4F). Finally, to confirm that the reduced numbers of IL-4-
producing CD4+ T cells in the memory 4getmMT mice reflected
a specific impairment in the generation and/or expansion of
Hp-specific Th2 cells, we exposed C57BL/6 and mMT mice to
two rounds of infection and drug treatment, challenged them
with L3 Hp, then restimulated purified CD4+ T cells from day
10 mLNs overnight with Hp antigen-pulsed APCs. We found
that CD4+ T cells from infectedmemory C57BL/6mice produced
elevated amounts of IL-4, IL-5, IL-10, and IL-13, whereas CD4+
T cells from infected memory mMT mice produced much lower
amounts of these cytokines (Figure 4G). Taken altogether, theseImmunity 30, 421–433, March 20, 2009 ª2009 Elsevier Inc. 425
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to Hp Are Dependent on B Cells
B cell-deficient mMT mice were irradiated and
reconstituted with BM from either 4get mice (4get
chimeras) or B cell-deficient 4get mice (4getmMT
chimeras). Chimeric mice were infected with Hp
and drug treated on day 21. On day 60, a cohort of
mice was analyzed (memory time point), and the
remainder of themicewere challengedwith L3Hp.
Mesenteric cells were analyzed for expression of
CD4, EGFP, and CD62L by flow cytometry.
(A and B) Plots gated on live CD4+ T cells and are
representative ofmice at (A) thememory time point
and (B) 5 days after challenge. The numbers in
each quadrant indicate the percentage of CD4+
T cells that express EGFP or CD62L.
(C) The number of EGFP+CD62loCD4+ T cells
present in the mLNs at the memory time point
and various times after challenge was determined.
(D and E) Cells from mLNs of (D) memory and (E)
day 5 postchallenge mice were restimulated with
plate-bound anti-CD3 in the presence of Brefeldin
A for 4 hr, and the expression of IL-4 and EGFP on
the CD4+ T cells was determined by flow cytome-
try. The percentage of EGFP+CD4+ cells coex-
pressing IL-4 is indicated in the plot (mean ± SD
of 5 mice per group).
(F) The number of EGFP+IL-4+CD4+ T cells present
in the mLNs at the memory time point and various
times after challenge was determined. Data in (C)
and (F) are shown as the mean ± SD of 4–5 mice
per group.
‘‘*’’: Statistically significant differences (p% 0.002) between the 4get and 4getmMT groups were found at each of the indicated time points. ‘‘#’’: Statistically signif-
icant differences (p% 0.03) between day 0 4getmMT mice and day 3 4getmMT mice are indicated.
(G) C57BL/6 and mMTmicewere infected withHp, drug treated, then challengedwith 200 L3Hp. Ten days later, CD4+ T cells were purified from pooledmLNs and
restimulated with Hp antigen-pulsed APCs overnight. Cytokines in the supernatants were quantified by cytometric bead array.
The results shown are representative of three independent experiments.data demonstrate that B cells, although not obligate for the
generation or maintenance of memory Th2 cells, are required
for support of the rapid expansion of functional antigen-specific
memory Th2 cells after challenge infection.
B Cells Regulate Th2 Memory Cell Responses
Independently of Ab Production
Our data indicated that B cells are required for the development
of an optimal memory Th2 cell response and are also necessary
for making class-switched Abs. To address whether B cells
control Th2 cell responses to Hp indirectly by making Ab that
regulates memory Th2 cell function, we measured Th2 cell
responses to Hp in chimeric mice that are B cell sufficient but
are unable to secrete Ab. To do this, we took advantage of the
mixed-BM chimera method (Lee et al., 2003), because this
method permitted us to selectively express or delete particular
genes in a specific hematopoietic lineage cell. In this experiment
(Figure S3), we used lethally irradiated mMT mice as hosts for all
groups. We reconstituted one group of mMT hosts with a mixture
of 75% 4getmMT BM and 25% ms–Aicda/ BM (B-ms–Aicda/
chimeras). Because all of the B cells in these chimeras must
develop from the ms–Aicda/ BM, the B cells in these mice
are unable to secrete Ab of any isotype. As controls, we recon-
stituted mMT hosts with a mixture of 75% 4getmMT BM and
25% C57BL/6 BM (B-wild-type [B-WT] chimeras). Because all
of the B cells in these chimeras must develop from the C57BL/6426 Immunity 30, 421–433, March 20, 2009 ª2009 Elsevier Inc.BM, the B cells are normal and able to produce Ab. Finally, we
reconstituted mMT hosts with 75% 4getmMT BM and 25% mMT
BM (mMT chimeras). These chimeras are B cell-deficient,
because none of the transferred BM can give rise to B cells.
Finally, 75% of all T cells in all three groups of chimeras are
derived from 4getmMT BM and therefore are able to express
EGFP when the IL-4 locus is transcribed.
We infected the chimeric mice with L3 Hp, treated them with
pyrantal pamoate, then challenged them with Hp larvae. Six
days later, we isolated cells from the mLNs and determined
the number of EGFP+CD62LloCD4+ T cells. As expected, the
number of EGFP+CD62Llo CD4+ T cells was greatly diminished
in the B cell-deficient mMT chimeras compared to the B-WT
controls (Figure 5A). In contrast, the number of EGFP+CD62Llo
CD4+ T cells was similar in B-WT chimeras and B-ms–Aicda/
chimeras (Figure 5A). Thus, the presence of B cells, even in the
absence of Ab, is sufficient for generation of a robust memory
Th2 cell response. These data, therefore, indicate that B cells
regulate memory CD4+ T cell responses to Hp through an
Ab-independent mechanism.
Antigen-Presenting Hp-Specific B Cells Are Necessary
for the Development of Functional Memory Th2 Cells
and for Protection
ToaddresshowBcells regulatememoryTh2cell responses toHp,
we asked whether B cells promote the differentiation of T cells
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Antigen-Presenting, Antigen-Specific B Cells But Does Not Require
Ab-Producing B Cells
(A) Irradiated mMT mice were reconstituted with 75% 4getmMT BM and 25%
mMT BM (mMT chimeras), with 75% 4getmMT BM and 25% C57BL/6 BM
(B-WT chimeras) or with 75% 4getmMT BM and 25% ms_Aicda/ BM
(B-ms_Aicda/ chimeras). The chimeric mice were infected with Hp, drug
treated, then challenged with 200 L3 Hp. EGFP+CD62LloCD4+ T cells in the
mLNs were enumerated by flow cytometry 6 days after challenge.
(B–D) Irradiated mMT mice were reconstituted with 100% mMT BM (mMT
chimeras), with 75% mMT BM and 25% C57BL/6 BM (B-WT chimeras) or with
75% mMT BM and 25% class II-deficient BM (B-MHCII-deficient chimeras).
The reconstituted mice were exposed to two rounds of Hp infection and
drug treatment and were then challenged with 200 L3Hp. (B) Parasite burdens
were determined for individual animals on day 21 and (C) serum titers of
Hp-specific IgG1 were determined by ELISA. (D) CD4+ T cells were purified
from pooled mLNs and stimulated with plate-bound anti-CD3 overnight. IL-4
levels in the T cell supernatants were determined by ELISA.
(E and F) B6mice andMD4 mMTmice were exposed to two rounds ofHp infec-
tion and drug treatment and were then challenged with L3 Hp. (E) Parasite
burdens were determined for individual animals. (F) Cells from the mLNs of
each group were pooled, and the CD4+ T cells were purified and stimulated
on anti-CD3-coated plates. Cytokine levels in the culture supernatants were
determined by cytokine bead array at 24 hr after restimulation.into effector Th2 cells and memory cells by presenting antigen.
To address this question, we generated mixed-BM chimeras
(FigureS4A) by using irradiatedmMThosts thatwere reconstituted
with 100% mMT BM (mMT chimeras), 75% mMT BM + 25%major
histocompatibility complex (MHC) class II-deficientBM (B-MHCII-
deficient chimeras), or 75% mMTBM+ 25%C57BL/6JBM (B-WT
chimeras). As expected, by 8 weeks after reconstitution, the
percentage of B cells present in peripheral blood was equivalent
between the B-WT and B-MHCII-deficient chimeras (Figure S4B).
Likewise, the number of B cells present in the spleens of these two
types of chimeras was indistinguishable (Figure S4C). The B cells
from the B-MHCII-deficient chimeras were class II deficient, but
other hematopoietic cells were able to express MHC class II
(Figure S4D). In contrast, B cells, as well as other APCs from the
B-WT chimeras, were able to express MHC class II, and the
percentage of MHC class II-expressing non-B cells was very
similar between all the groups (Figure S4D). These chimeric mice
were exposed to two roundsof L3Hp infection anddrug treatment
and were then challenged with L3 Hp. As expected, the B-WT
chimeras cleared the infection, whereas the mMT chimeras did
not (Figure 5B). Interestingly, the B-MHCII-deficient chimeras
were also unable to clear the infection (Figure 5B), demonstrating
that cognate interactions specifically between B cells and CD4+
T cells are important for immunity to Hp. Next, we measured the
titers ofHp-specific Ab in the serumof chimericmice to determine
whether antigenpresentationbyBcellswasnecessary toproduce
the protective isotype-switched Ab. As shown in Figure 5C,
Hp-specific IgG1 was easily detected in the serum of B-WT
chimeras, but not in mMT chimeras or B-MHCII-deficient
chimeras. To evaluate the CD4+ T cell response in the Hp chal-
lenged mice, we purified CD4+ T cells, restimulated them with
anti-CD3overnight, andmeasured IL-4accumulation in the super-
natant. T cells from B-WT chimeras produced large quantities of
IL-4, whereas T cells from mMT and B-MHCII-deficient chimeras
produced much smaller quantities (Figure 5D).
Finally, to address whether the protective B cells had to be
antigen specific to promote protection from Hp, we crossed
BCR-transgenic MD4 mice (Goodnow et al., 1988) onto the
B cell-deficient mMT background (MD4mMT) to generate mice
with a monoclonal repertoire of B cells specific for an irrelevant
antigen (lysozyme). These mice were exposed to two rounds of
infection and drug treatment and then challenged with L3 Hp.
Interestingly, the MD4mMT mice were not protected against Hp
challenge infection (Figure 5E). Furthermore, Th2 cell cytokine
production by the anti-CD3-restimulated CD4+ T cells isolated
from the mLNs of the MD4mMT mice was greatly diminished
relative to the response of CD4+ T cells from C57BL/6J mice
(Figure 5F). Together, these data show that cognate interactions
between B and T cells are required for the activation and differ-
entation of Hp-specific B and T cells and that this cognate inter-
action is necessary for the development of a protective memory
response to Hp.
IL-4-Primed B Cells Are Required for Immunity to Hp
Protective immunity to Hp is dependent on IL-4-producing Th2
cells (Liu et al., 2004). We previously showed that B cells primed
The data are shown as the mean ± SD of 4–5 mice per group. The results
shown are representative of two or more independent experiments.Immunity 30, 421–433, March 20, 2009 ª2009 Elsevier Inc. 427
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Is Required for the In Vivo Development
of Be-2 Cells and for Immunity to Hp
Bcell-deficient JHDmicewere irradiated and recon-
stituted with 80% JHD BM and 20% 4get BM
(B-4get) orwith 80%JHDBMand20%4get-Il4ra/
BM (B-4get-Il4ra/). Reconstituted mice were
exposed to two rounds of L3 Hp infection and drug
treatment and then challenged with 200 L3 Hp.
(A) The number of live (PIneg), EGFP-expressing
CD19+CD4neg B cells in the mLNs was determined
by flow cytometry. EGFP+ B cells present in the
mLNsof uninfected 4get or 4get-Il4ra/mice repre-
sent% 0.01% of the total B cell pool or 100–300 B
cells per mLN (Harris et al., 2005b).
(B) Titers of Hp-specific IgG1 in serum were deter-
mined by ELISA.
(C) Adult parasites were enumerated by counting.
The results shownare representativeof two indepen-
dent experiments.in the presence of IL-4 (Be-2 cells) are excellent antigen-pre-
senting cells and promote the in vitro differentiation of naive
T cells into IL-4-producing Th2 cells (Harris et al., 2000). To
test whether IL-4-primed B cells are necessary for protection
from Hp, we backcrossed 4get IL-4 reporter mice to the
BALB/c genetic background and then intercrossed these mice
with the IL-4Ra-deficient (Il4ra/) mice to generate 4get-
Il4ra/ mice. Then, we generated mixed-BM chimeras by
lethally irradiating B cell-deficient JHD mice and reconstituting
themwith a mixture of 80% JHD BM and 20% 4get IL-4-reporter
BM (B-4get chimeras). Because all the B cells in these chimeras
develop from the 4get BM, they will express EGFP in any cell in
which IL-4 transcripts are also expressed (Figure S5A). We also
irradiated a second group of JHD mice and reconstituted these
animals with 80% JHD BM and 20% 4get-Il4ra/ BM. The B
cells in these mice (B-4getIl4ra/ chimeras) develop from the
4get-Il4ra/ BM and will express EGFP when the IL-4 locus is
transcribed. However, these reporter B cells are unable to
express the IL-4Ra subunit, preventing them from responding
to IL-4 or IL-13 and blocking their ability to differentiate into
Be-2 cells (Harris et al., 2005b). We exposed both groups of
chimeric mice to two rounds of Hp and drug treatment and
then challenged them with Hp larvae. Similar to our previous
observations (Harris et al., 2005b), a small number of B cells
from the mLNs of the B-4get chimeras expressed EGFP
(Figure 6A and Figure S5B), indicating that these B cells are tran-
scribing the IL-4 gene. In contrast, the number of IL-4Ra-defi-
cient 4getB cells expressing EGFP (Figure 6A and Figure S5B)
was significantly (p % 0.03) lower than that seen in the B-WT
chimeras, demonstrating that IL-4-producing Be-2 cells do not
develop efficiently in vivo when B cells cannot receive an IL-4
or IL-13 signal.
To test whether IL-4Ra-expressing B cells are needed for
protection from Hp, we measured Hp-specific Ab responses
and parasite burden in the chimeric mice. The B-4get chimeras
made a robust Hp-specific IgG1 response (Figure 6B) and effi-
ciently prevented parasite emergence (Figure 6C). In contrast,
the B-4get-Il4ra/ chimeras did not produce Hp-specific IgG1
(Figure 6B) and were not protected from the challenge infection
(Figure 6C). Together, these data demonstrate that B cells428 Immunity 30, 421–433, March 20, 2009 ª2009 Elsevier Inc.primed in the presence of IL-4 (Be-2 cells) are required for
protection from Hp challenge infections.
B Cell-Derived Cytokines Are Necessary for Effective
Humoral and Cellular Immunity to Hp
Prior data from our laboratory showed that Be-2 cells can regu-
late Th2 cell differentiation in vitro by producing IL-4 (Harris et al.,
2000). Given that IL-4 is a critical cytokine for protection from Hp
(Liu et al., 2004) and that B cells make IL-4 in response to Hp
infection (Harris et al., 2000), we assessed whether IL-4-
expressing B cells are necessary for protective immunity. We
therefore produced mixed BM chimeras in irradiated mMT hosts,
making chimeras with normal B cells (B-WT chimeras), chimeras
with IL-4-deficient B cells (B-Il4/ chimeras), chimeras with IL-4
deficiency in all hematopoietic lineages (Il4/ chimeras), and
chimeras that are B deficient (mMT chimeras) (Figure S6). We
exposed the chimeras to two rounds of Hp infection and drug
treatment and then challenged the mice again with L3Hp. As ex-
pected, the Il4/ chimeras did not clear the challenge infection.
However, B-Il4/ mice cleared the infection (Figure 7A) and
made a normal Hp-specific IgG1 response (not shown). Thus,
although IL-4 is critical for immune control of Hp, IL-4-producing
B cells are not necessary for protection.
Because Be-2 cells make cytokines other than IL-4, including
IL-10, LTa, IL-2, and TNFa (Harris et al., 2000), we generated
additional mixed BM chimeras (see Figure S6) to test whether
the production of these cytokines by B cells was required for
effective protection against Hp. We found that neither IL-10
nor LTa production by B cells is necessary for protection from
Hp challenge infections (not shown). However, mice with IL-2-
deficient B cells exhibited only partial protection from Hp chal-
lenge infection and presented with a parasite burden that,
although lower than that observed in the B-deficient mMT
chimeras, was significantly (p < 0.001) higher than that in the
B-WT chimeras (Figure 7B). Likewise, mice with TNFa-deficient
(Tnf/) B cells were only partially protected after challenge
with Hp and exhibited a parasite burden that was intermediate
between the protected B-WT and the susceptible mMT chimeras
(Figure 7C). Interestingly, the parasite burdens in the animals that
lacked expression of IL-2 or TNFa specifically within B lineage
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that were deficient in TNFa or IL-2 in all hematopoietic lineages
(Figures 7B and 7C). Importantly, the chimeras with cytokine-
deficient B cells did not clear the adult parasites even as far
out as day 21 (data not shown), indicating that these B cells
were not able to prevent the establishment of a chronic infection.
Thus, B cell-derived IL-2 and TNFa are necessary for the estab-
lishment of protective immunity to Hp.
To address how IL-2 and TNFa production by B cells regulates
immunity to Hp, we analyzed cellular and humoral immune
responses after challenge in the chimeric mice. We found that
T cells from B-Il2/ and Il2/ chimeras produced very little
IL-4 after restimulation with anti-CD3, relative to T cells from
B-WT chimeras (Figure 7D). In contrast, the numbers of IL-4-
producing T cells in B-Tnf/ or Tnf/ mice were actually
greater than the number of IL-4-producing T cells present in
themLN of B-WT chimeras (Figure 7E). Next, to address whether
IL-2- or TNFa-producing B cells modulate humoral immunity to
Hp, we measured Hp-specific IgG1 titers in the serum of the
Figure 7. Protective Humoral and Cellular
Immune Responses to Hp Are Controlled
by Cytokine-Producing Effector B Cells
(A) Irradiated mMT mice were reconstituted with
100% mMT BM (mMT chimeras), with 75% mMT
BM and 25% C57BL/6 BM (B-WT chimeras) or
with 75% mMT BM and 25% Il4/ BM (B-Il4/
chimeras). The reconstituted mice were exposed
to two rounds of L3 Hp infection and drug treat-
ment and were then challenged with L3 Hp. Para-
site burden was determined on day 21.
(B, D, F) Irradiated mMT mice were reconstituted
with 75% mMT BM and 25% Il2/ BM (B-Il2/
chimeras), with 100% Il2/ BM (Il2/ chimeras),
with 100% mMT BM (mMT chimeras), or with 75%
mMT BM and 25% C57BL/6 BM (B-WT chimeras).
(C, E, G) Irradiated mMT mice were reconstituted
with 75% mMT BM and 25% Tnf/ BM (B-Tnf/
chimeras), with 100% Tnf/ BM (Tnf/
chimeras), with 100% mMT BM (mMT chimeras),
or with 75% mMT BM and 25% C57BL/6 BM
(B-WT chimeras). In separate experiments, the
cytokine chimeras along with control B-WT and
mMT chimeras were infected and drug-treated
twice and then challenged with L3 Hp.
Parasite burden in the lumen was determined on
(B) day 12 or (C) day 10 after infection.
(D and E) Cells from mLNs of cytokine chimeras
and controls were stimulated in the presence of
Brefeldin A for 5 hr on anti-CD3-coated plates,
and the number of IL-4-producing CD4+ T cells
was determined by flow cytometry.
(F and G) Serum titers of Hp-specific IgG1 were
determined by ELISA.
All data are shown as the mean ± SD ofR 5 mice
per group. The results shown are representative of
two or more independent experiments.
chimeric mice. Hp-specific IgG1 titers
were reduced in the B-Il2/ chimeras,
compared to the IgG1 titers observed in
B-WT mice (Figure 7F). The titers of Hp-
specific IgG1 were also reduced in the
B-Tnf/ and Tnf/ chimeras (Figure 7G) compared to those
in B-WT mice. Thus, these data show that B cell-derived TNFa
regulates humoral, but not cellular, immunity to Hp, whereas
IL-2 made by B cells modulates both cellular and humoral immu-
nity to this pathogen. Taken altogether, the data show that
B cells are necessary for both humoral and cellular immune
responses to Hp and that cytokine production by B cells is one
critical mechanism by which they mediate their protective
effects. The implications of these findings are discussed.
DISCUSSION
The data presented here show that B cells are an essential
component of immunity to Hp and that B cells mediate their
protective effects by regulating both the humoral and the cellular
immune response to this parasite. To regulate immunity to Hp,
B cells utilize multiple effector mechanisms, which include
producing Ab, presenting antigen, and secreting cytokines.
Our data show that ms–Aicda/ mice, which lack the ability to
Immunity 30, 421–433, March 20, 2009 ª2009 Elsevier Inc. 429
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tected in a rechallenge infection with Hp. Although Ab is gener-
ated in response to infection with a variety of helminths, the
protective role for Ab in these infections is variable, and no
obvious role for Hp-specific Ab has been reported. IgE-deficient
(Anthony et al., 2007; Finkelman et al., 1997; W.W. and F.L.,
unpublished data) and Fc3R1a-deficient (W.W. and F.L., unpub-
lished data)mice are immune to rechallenge infectionwith L3Hp.
Furthermore, transfer ofHp-immune serum to naive mice did not
confer protection against Hp challenge (Penttila et al., 1984),
minimally suggesting that Ab by itself is not sufficient to mediate
protection. Our new data clearly show a role for class-switched
Ab and affinity-matured Ab in protection from Hp. Although we
do not yet know how Ab facilitates clearance of the larvae, it
may be mediated by FcR-expressing cells, given that mice defi-
cient in the Fc common g chain subunit (FcER1g) are susceptible
to challenge infection (W.W. and F.L., unpublished data).
Interestingly, an older report showed that naive animals
receiving both Hp-specific immune serum and immune lympho-
cytes are protected fromHp infection (Behnke and Parish, 1981),
suggesting that the combination of Hp-specific Ab and memory
lymphocytes is essential for immunity. However, the transfer of
Hp immune serum to mMT mice that were previously infected
(to elicit memory T cells) did not provide protection from Hp
infection. This surprising result suggested to us that the cellular
memory immune response may also be compromised in
B cell-deficient mice. In fact, we found that B cells play a critical
role in the primary expansion and differentiation of IL-4-
producing effector Th2 cells in response to Hp infection. These
data are consistent with previous observations showing that
primary Th2 cell responses to protein antigens delivered with
live N. brasiliensis larvae (Liu et al., 2007), as well as protein anti-
gens delivered in alum (Crawford et al., 2006), are dependent on
B cells. Although B cells were not required for the initial activation
of Ag-specific T cells in these experiments, the B cells appear to
play an important role in primary Th2 cell expansion (Crawford
et al., 2006; Liu et al., 2007; Ronet et al., 2008). B cells also
appear to be important for memory Th2 cell responses to protein
antigens delivered in alum (Linton et al., 2000), and consistent
with this, we find that B cells play a key role in regulating memory
Th2 cell responses to Hp. Interestingly, we find that although the
number of memory Th2 cells is lower in B cell-deficient mice than
in WT mice, the difference is less than 2-fold, and these cells are
equally able to produce IL-4 upon restimulation. However, we
find that the expansion of memory Th2 cells and their subse-
quent differentiation into secondary cytokine-secreting effector
cells is highly dependent on B cells. Although we do not yet
know whether B cells directly alter the quality of memory
T cells that are generated during the primary immune response
or whether B cells are necessary for memory T cell reactivation
during the secondary immune response, our data show that
B cells are important for the expansion of cytokine-producing
effector Th2 cells in both primary and secondary responses
to Hp.
Given the requirement for Th2 cells in immunity to Hp, it is
reasonable to postulate that the poor Th2 cell response induced
in the B cell-deficient animals contributes to the lack of immunity
seen in these mice. Importantly, by using mMT hosts for all of our
BM chimeras, we were able to demonstrate that the changes in430 Immunity 30, 421–433, March 20, 2009 ª2009 Elsevier Inc.T cell immunity that we observed were not simply due to the
lymphoid-tissue defects associated with the loss of B cells
during fetal development (Golovkina et al., 1999; Ngo et al.,
2001). However, it is certainly possible that the loss of B cells
during infection led to changes in other T cell subsets. We did
not observe an increase in the number of IFNg-expressing
Hp-specific T cells, indicating that the loss of B cells did not shift
the response from a type 2 to a type 1 response (data not shown).
We did, however, find that the number of antigen-specific IL-10-,
IL-5-, or IL-13-producing T cells was greatly reduced in the
B cell-deficient mice, and we also observed reductions in the
numbers of Foxp3+CD25+ T cells (data not shown). It is important
to note that we found no evidence that IL-10 expressed by any
cell type is necessary for protection from Hp (data not shown),
suggesting that IL-10-producing Tregs are not critically impor-
tant for Hp clearance. Thus, although we cannot exclude the
possibility that B cells regulate immunity to Hp by affecting other
T cell subsets, we can conclude that one important way in which
B cells regulate cellular immune responses toHp is by controlling
primary and memory Th2 cell expansion and differentiation.
How might B cells affect Th2 cell expansion and differentia-
tion? We show that MHC class II-dependent interactions
between B and T cells are necessary for the development of
effective Th2 cell responses to Hp, suggesting a potential role
for B cell-mediated costimulation. One likely candidate that we
considered was OX40L, given that expression of OX40L on
B cells is necessary for the development of optimal memory
Th2 cell responses to OVA and alum (Linton et al., 2003) and
that OX40L is required for protection fromHp challenge infection
(Ekkens et al., 2003). However, we found that OX40L expression
by B cells is not required for the generation of a protective
humoral or cellular immune response to Hp (data not shown).
Instead, we found that mice lacking IL-4Ra specifically on B cells
are unable to make an effective memory response toHp, leading
us to conclude that B cells primed in the presence of IL-4 (or
Be-2-‘‘like’’ B cells), are required for immunity to Hp. However,
despite the ability of Be-2 cells to make IL-4, IL-4-producing
B cells are not required for the generation of a protective immune
response to Hp.
Be-2 cells also make large quantities of IL-2 (Harris et al.,
2000), a cytokine that is known to play a central role in Th2 cell
differentiation (Cote-Sierra et al., 2004). In fact, we show that
IL-2 made specifically by B cells is required for protection from
Hp. Furthermore, we found that the loss of IL-2-producing B cells
correlates with a significant decrease in the number of IL-4-
producing Th2 cells in mice rechallenged with Hp. In agreement
with these findings, anti-IL-2 treatment of BALB/c mice suscep-
tible to L. major results in the suppression of the nonprotective
Th2 cell response and the induction of a protective IFNg
response (Heinzel et al., 1993). Interestingly, B cells were shown
to be the major cellular source of IL-2 in the nonprotected
L. major-infected BALB/c mice (Heinzel et al., 1993), and B cells
are obligate for the noncuring phenotype of BALB/c mice (Ronet
et al., 2008). Thus, it is tempting to speculate that IL-2-producing
Be-2 cells may prevent clearance of L. major in BALB/c mice.
Although IL-2 is not considered a Th2 cell-polarizing cytokine
and does not promote Th2 cell survival or cell growth (Cote-
Sierra et al., 2004), it does improve accessibility of transcription
factors to the IL-4 locus—thereby controlling Th2 cell
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absence of IL-2-producing B cells, it was not surprising to find
that the class-switched Ab response to Hp was also reduced.
It was, however, surprising to find that mice that completely
lack the ability to produce IL-2 in hematopoietic lineage cells
produced nearly normal levels of Hp-specific IgG1. Although
we do not know the reason for this, we speculate that the loss
of Tregs in these mice may enhance the humoral immune
response to the point that it overcomes the reduction seen in
the mice that are IL-2 deficient selectively in B lineage cells.
Regardless, the impairment in protection against Hp observed
in the absence of IL-2-producing B cells is probably due to the
attenuation of both the cellular and the humoral immune
responses to Hp.
IL-2 was not the only cytokine made by Be-2 cells that regu-
lates immunity to Hp; we found that chimeric mice in which the
B cells are selectively unable to produce TNFa do not develop
effective protection from Hp. These results were somewhat
surprising, given that Hp infection induces a dominant Th2 cell
response and TNFa is not a cytokine traditionally associated
with Th2 cell responses. Indeed, TNFa production by B cells
has been shown to enhance IFNg production by T cells in T. gon-
dii-infected mice (Menard et al., 2007). However, there are
several examples in which TNFa regulates Th2 cell responses
(Cazzola and Polosa, 2006)—most notably in mice infected
with the nematode T. muris (Artis et al., 1999). Although TNFa
is not required for the development of Th2 cells after infection
with T. muris (Artis et al., 1999) or, as we show, after infection
with Hp, TNFa is important for modulating the activity of IL-13
during T. muris expulsion (Artis et al., 1999). At this point, we
do not know whether B cell-derived TNFa regulates the IL-13
response to Hp—or even whether IL-13 is necessary for protec-
tion from Hp. However, our data do show that the loss of TNFa-
producing B cells leads to a significant (p% 0.001) decline in the
class-switched Ab response. This result was unexpected, given
that TNFa production by B cells is not required for generating
Ab responses to sheep red blood cells (Endres et al., 1999).
However, our preliminary results indicate that long-lived Ab
responses to mucosal antigens, but not systemic antigens, are
dependent on TNFa-producing B cells (W.W. and F.E.L., unpub-
lished observation). In any event, given the importance of Ab in
protection from Hp, it is reasonable to propose that one of
the—perhaps multiple—ways in which TNFa-producing B cells
contribute to Hp immunity is by promoting enduring Ab
responses.
In summary, our data demonstrate that B cells use a variety of
effector mechanisms, including secretion of Ab, presentation of
antigen, enhancement of primary and memory Th2 cell
responses, and production of cytokines, to promote immunity
to Hp. Although it has been known for many years that B cells
have the ability to carry out each of these functions, these data
demonstrate that B cells must successfully carry out every one
of these functions in order to protect the host against challenge
infection with a single pathogen. Importantly, we also showed
that cytokines made by B cells appear to control both the activity
of the B cells themselves and the expansion and differentiation of
effector and memory Th2 cells. Thus, our experiments fill an
important gap, showing that multiple cytokines made by B cells
regulate both humoral and cellular immune responses to infec-tious organisms. In the context of immunity to particular patho-
gens, cytokine production by B cells can clearly be beneficial.
However, in the context of immune responses to ‘‘inappropriate’’
stimuli, such as autoantigens and allergens, these same cyto-
kine-producing effector B cells may facilitate a positive feedback
loop between B and T cells, leading to amplification and immu-
nopathology. Thus, cytokine-producing effector B cell subsets
have the potential to influence both protective and damaging
immune responses in vivo and, therefore, may represent future
targets for vaccination-, inhibition-, and depletion-based thera-
peutics.
EXPERIMENTAL PROCEDURES
Mice and BM Chimeras
All animals used in these experiments were bred and maintained in the Tru-
deau Institute Animal Breeding Facility. All procedures involving animals
were approved by the Trudeau Institute Institutional Animal Care and Use
Committee and were conducted in accordance with the principles outlined
by the National Research Council. Mouse strains and their origins are
described in Table S1. We generated BM chimeric mice by lethally irradiating
recipients with 950 Rads from a 137Cs source and reconstituting themwith 107
total BM cells (Lund et al., 2006). BM chimeric mice were allowed to reconsti-
tute for 8–12 weeks before infection. See Figure S1 for description of conven-
tional reciprocal BM chimeras and representative reconstitution profile. See
Figures S3–S6 for description of mixed BM chimeras used in the individual
experiments, and see Figure S4 for representative reconstitution profiles.
Hp Stocks, Antigen, and Infection
Hp stocks were routinely passaged through BALB/cmice. Soluble antigenwas
prepared from adult parasites as previously described (Harris et al., 2000).
Mice were infected by gavage with 100–200 L3 Hp larvae. Adult Hp parasites
were eliminated by two oral administrations of 100 mg/kg pyrantel pamoate
(Effcon Laboratories) delivered 5 days apart. Mice were challenged 10 days
after the last drug treatment with 200 L3Hp. AdultHp parasites in the intestinal
lumen were enumerated by visual inspection under a dissecting microscope at
any time between days 10–21 after challenge infection, given that parasite
burden in the intestine peaked 10 days after infection and remained at
plateau levels for at least 21 days (Figure 1).
Intracellular Staining and Flow Cytometry
Single-cell suspensions from mLNs were stimulated on anti-CD3-coated
plates (2 mg/ml) in the presence of Brefeldin-A (10 mg/ml) for 4–5 hr. The
restimulated cells were stained with anti-CD4, fixed in 4% paraformaldehyde,
permeabilized with 0.1% NP40, and stained with Abs against EGFP (Invitro-
gen) and IL-4 (BD Biosciences). Conjugated Abs to CD19, FAS, CD62L, and
CD4+ were purchased from BD Biosciences. Peanut agglutinin (PNA) was
obtained from Vector Laboratories. Samples were analyzed with a dual laser
FACSCalibur or a FACScan (BD Biosciences) with a multicolor upgrade (Cytek
Development). Data were analyzed with FlowJo software (TreeStar).
T Cell Purification and Restimulation
CD4+ T cells were purified (95% purity) frommLNs by positive selection over
LS columns with anti-CD4+ MACS beads (Miltenyi Biotec). Purified CD4+
T cells (5 3 105/ml) were stimulated with plate-bound anti-CD3 (10 mg/ml) or
with mytomycin C-treated (10 mg/ml), Hp antigen-pulsed (20 mg/ml), T cell-
depleted splenocytes at a 1:1 ratio at 13 106/ml. Supernatants were removed
for analysis 24 hr later.
ELISAs and Cytometric Bead Array
Cytokines were measured by ELISA with Ab pairs from BD Biosciences or by
Luminex-based multiplex cytometric bead array with Beadlyte multicytokine
beads (Upstate Biotech). Hp-specific Abs were assayed by ELISA with the
use of plates coated with 2 mg/ml Hp antigen. Serum samples were serially
diluted, and bound Abs were detected with anti-mouse IgM or anti-mouseImmunity 30, 421–433, March 20, 2009 ª2009 Elsevier Inc. 431
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Regulation of Th2 Immunity by Effector B CellsIgG1 (Southern Biotech). Total IgE wasmeasured by the use of anti-mouse IgE
Ab pairs from BD in ELISAS.
Serum Transfers
B6 donormice were infected with 200 L3Hp, treated with pyrantal pamoate on
day 30, then rechallenged with 200 L3 Hp 2 wk later. Hp immune serum was
collected from the euthanized donor mice on day 21. We injected 200 ml of
the Hp immune serum or normal mouse serum i.p. into memory mMT and B6
recipients on days 2, 0, and 2 of a challenge infection with Hp.
Statistical Analyses
Data were analyzed with the unpaired Student’s t test via Prism 4.0 (GraphPad
Software). Values of p% 0.05 were considered significant.
SUPPLEMENTAL DATA
Supplemental Data include six figures and one table and can be found with
this article online at http://www.immunity.com/supplemental/S1074-
7613(09)00101-0.
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